Reading Our Genome is Tough, But Epigenetics is Giving Us Valuable Clues
By Marcus Woo,
Wired
| 02. 19. 2015
Untitled Document
When scientists sequenced the human genome a decade ago, they hoped to unlock the code of life, the sequence of molecules lined up in every cell that, summed together, made a person a person—and possibly reveal new ways to understand and treat diseases. But the results turned out to be opaque. Biologist Eric Lander, who helped lead the effort, famously summed up the results in seven words: “Genome: Bought the book; hard to read.”
So the research community went looking for CliffsNotes. A decade ago scientists started looking into the “epigenome,” chemical modifications to DNA that tell cells which genes to turn on or turn off. This week that project got a huge data dump—24 journal articles laying out what the genomicists know so far about 111 different cell types, the inner lives of brains, hearts, blood, and skin. “It is giving us a view of the living, breathing genome in motion, as opposed to a static picture of DNA,” says Manolis Kellis, a computational biologist at MIT who worked on two of the new papers.
Just about every...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...